Pentwater Capital Management LP Pure Tech Health PLC Transaction History
Pentwater Capital Management LP
- $8.71 Billion
- Q4 2024
A detailed history of Pentwater Capital Management LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 24,111 shares of PRTC stock, worth $445,330. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,111
Previous 25,000
3.56%
Holding current value
$445,330
Previous $519,000
14.26%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PRTC
# of Institutions
6Shares Held
373KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC302KShares$5.58 Million0.27% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny45.3KShares$836,0260.0% of portfolio
-
Ubs Group Ag1.9KShares$35,1480.0% of portfolio
-
Morgan Stanley New York, NY100Shares$1,8470.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $515M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...